1. de Fost M, van Trotsenburg AS, van Santen HM, Endert E, van den Elzen C, Kamsteeg EJ, et al. Familial neurohypophyseal diabetes insipidus due to a novel mutation in the arginine vasopressin-neurophysin II gene. Eur J Endocrinol. 2011; 165:161–165. PMID:
21498630.
Article
2. Abu Libdeh A, Levy-Khademi F, Abdulhadi-Atwan M, Bosin E, Korner M, White PC, et al. Autosomal recessive familial neurohypophyseal diabetes insipidus: onset in early infancy. Eur J Endocrinol. 2010; 162:221–226. PMID:
19897608.
3. Baylis PH, Cheetham T. Diabetes insipidus. Arch Dis Child. 1998; 79:84–89. PMID:
9771260.
4. Kaplowitz PB, D'Ercole AJ, Robertson GL. Radioimmunoassay of vasopressin in familial cental diabetes insipidus. J Pediatr. 1982; 100:76–81. PMID:
7057320.
5. Lee YW, Lee KW, Ryu JW, Mok JO, Ki CS, Park HK, et al. Mutation of Glu78 of the AVP-NPII gene impairs neurophysin as a carrier protein for arginine vasopressin in a family with neurohypophyseal diabetes insipidus. Ann Clin Lab Sci. 2008; 38:12–14. PMID:
18316776.
6. Ito M, Mori Y, Oiso Y, Saito H. A single base substitution in the coding region for neurophysin II associated with familial central diabetes insipidus. J Clin Invest. 1991; 87:725–728. PMID:
1840604.
Article
7. Christensen JH, Rittig S. Familial neurohypophyseal diabetes insipidus: an update. Semin Nephrol. 2006; 26:209–223. PMID:
16713494.
8. Hedrich CM, Zachurzok-Buczynska A, Gawlik A, Russ S, Hahn G, Koehler K, et al. Autosomal dominant neurohypophyseal diabetes insipidus in two families. Molecular analysis of the vasopressin-neurophysin II gene and functional studies of three missense mutations. Horm Res. 2009; 71:111–119. PMID:
19129716.
9. Robertson GL, Shelton RL, Athar S. The osmoregulation of vasopressin. Kidney Int. 1976; 10:25–37. PMID:
181630.
Article
10. Tae HJ, Baek KH, Shim SM, Yoo SJ, Kang MI, Cha BY, et al. A novel splice site mutation of the arginine vasopressin-neurophysin II gene identified in a kindred with autosomal dominant familial neurohypophyseal diabetes insipidus. Mol Genet Metab. 2005; 86:307–313. PMID:
16006166.
Article
11. Maghnie M, Villa A, Arico M, Larizza D, Pezzotta S, Beluffi G, et al. Correlation between magnetic resonance imaging of posterior pituitary and neurohypophyseal function in children with diabetes insipidus. J Clin Endocrinol Metab. 1992; 74:795–800. PMID:
1548343.
12. Fluck CE, Deladoey J, Nayak S, Zeller O, Kopp P, Mullis PE. Autosomal dominant neurohypophyseal diabetes insipidus in a Swiss family, caused by a novel mutation (C59Delta/A60W) in the neurophysin moiety of preprovasopressin-neurophysin II (AVP-NP II). Eur J Endocrinol. 2001; 145:439–444. PMID:
11581002.
Article
13. Sausville E, Carney D, Battey J. The human vasopressin gene is linked to the oxytocin gene and is selectively expressed in a cultured lung cancer cell line. J Biol Chem. 1985; 260:10236–10241. PMID:
2991279.
Article
14. Eubanks S, Nguyen TL, Deeb R, Villafania A, Alfadhli A, Breslow E. Effects of diabetes insipidus mutations on neurophysin folding and function. J Biol Chem. 2001; 276:29671–29680. PMID:
11395505.
Article
15. Christensen JH, Siggaard C, Corydon TJ, deSanctis L, Kovacs L, Robertson GL, et al. Six novel mutations in the arginine vasopressin gene in 15 kindreds with autosomal dominant familial neurohypophyseal diabetes insipidus give further insight into the pathogenesis. Eur J Hum Genet. 2004; 12:44–51. PMID:
14673472.
Article
16. Rittig S, Robertson GL, Siggaard C, Kovacs L, Gregersen N, Nyborg J, et al. Identification of 13 new mutations in the vasopressin-neurophysin II gene in 17 kindreds with familial autosomal dominant neurohypophyseal diabetes insipidus. Am J Hum Genet. 1996; 58:107–117. PMID:
8554046.